Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP222142.RAWGcd-ZPLjd_qrdqlV3INC5Fg6Bp9CBrT67pS_nSc7-w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP222142.RAWGcd-ZPLjd_qrdqlV3INC5Fg6Bp9CBrT67pS_nSc7-w130_assertion type Assertion NP222142.RAWGcd-ZPLjd_qrdqlV3INC5Fg6Bp9CBrT67pS_nSc7-w130_head.
- NP222142.RAWGcd-ZPLjd_qrdqlV3INC5Fg6Bp9CBrT67pS_nSc7-w130_assertion description "[We used genomic DNA of 48 patients with focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) to screen for ACTN4 mutations by high-resolution melting analysis (HRM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222142.RAWGcd-ZPLjd_qrdqlV3INC5Fg6Bp9CBrT67pS_nSc7-w130_provenance.
- NP222142.RAWGcd-ZPLjd_qrdqlV3INC5Fg6Bp9CBrT67pS_nSc7-w130_assertion evidence source_evidence_literature NP222142.RAWGcd-ZPLjd_qrdqlV3INC5Fg6Bp9CBrT67pS_nSc7-w130_provenance.
- NP222142.RAWGcd-ZPLjd_qrdqlV3INC5Fg6Bp9CBrT67pS_nSc7-w130_assertion SIO_000772 23890478 NP222142.RAWGcd-ZPLjd_qrdqlV3INC5Fg6Bp9CBrT67pS_nSc7-w130_provenance.
- NP222142.RAWGcd-ZPLjd_qrdqlV3INC5Fg6Bp9CBrT67pS_nSc7-w130_assertion wasDerivedFrom befree-20150227 NP222142.RAWGcd-ZPLjd_qrdqlV3INC5Fg6Bp9CBrT67pS_nSc7-w130_provenance.
- NP222142.RAWGcd-ZPLjd_qrdqlV3INC5Fg6Bp9CBrT67pS_nSc7-w130_assertion wasGeneratedBy ECO_0000203 NP222142.RAWGcd-ZPLjd_qrdqlV3INC5Fg6Bp9CBrT67pS_nSc7-w130_provenance.